Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Exp Gerontol. 2014 Jan 15;0:84–89. doi: 10.1016/j.exger.2014.01.010

Table 2.

Summary of the four study parameters and dates of sample collection

Sample collected at baseline visit (1994–5) Sample collected in 2007
ID Date of
sample
collection
Anti-
CMV
IgG
titers*
(EU/ml)
CMV
DNA
IL-6
(pg/ml)
CMV
pp65
(NLV)
- CD8+
T cells
(%)
Date of
sample
collection
Anti-
CMV
IgG
titers
(EU/ml)
CMV
DNA
IL-6
(pg/ml)
CMV
pp65
(NLV)
- CD8+
T cells
(%)
1 11/21/1994 1.73 1.91 11/07/2007 -** 1.04
2 10/10/1995 - 1.14 11/06/2007 - 0.95
3 08/10/1995 - 1.04 10/30/2007 - 0.93
4 07/03/1995 - 1.22 0.04 11/20/2007 - 1.51 0.02
5 06/13/1995 14.05 1.28 0.02 11/21/2007 15.51 0.70 0.02
6 01/25/1995 7.35 0.55 11/16/2007 9.76 0.38
7 09/13/1995 9.79 1.24 12/19/2007 11.13 0.89
8 12/22/1994 11.23 1.14 0.02 10/29/2007 10.91 1.44 0.01
9 12/05/1995 10.16 + 3.38 11/20/2007 12.88 + 3.88
10 03/16/1995 8.15 + 2.51 11/27/2007 9.24 + 2.36
11 12/04/1995 11.48 + 3.53 0.85 11/20/2007 11.01 + 3.43 0.88
12 09/27/1995 17.16 + 4.11 0.64 11/21/2007 17.48 + 3.43 0.83
13 06/21/1995 7.54 + 2.58 11/20/2007 7.753 + 2.41
14 10/19/1995 16.53 + 2.5 10/22/2007 16.31 + 2.89
15 12/11/1995 3.18 + 2.84 12/07/2007 5.16 + 4.24
*

Values below the predetermined cut-off value for CMV-seropositivity (1.2 EU/ml) were recorded (−);

**

The absolute anti-CMV IgG titer value was 1.12 EU/ml.